Kyuboem Han

This inventor holds 9 USPTO granted patents and 12 published patent applications and 3 EPO patents. Top assignees: Paean Biotechnology Inc., Lg Chemical Ltd., Paean Aesthetics Inc.. Active years: 2002-2026.

USPTO Granted Patents = 9 (Patent Applications = 12)

% Patents Active = 88.9

EPO Patents = 3 (Patent Applications = 12)

Average Co-Inventor Count = 3.1

ph-index = 2

Forward Citations = 8(Granted Patents)

Location History:

Taejon-si, KR (2002 - 2003)
Daejeon, KR (2006 - 2022)
Yuseong-gu Daejeon, KR (2020 - 2022)

Company Filing History:

4 out of 4

Paean Biotechnology Inc.

Paean Aesthetics Inc.

patents

Years Active: 2002-2026

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12636316 - PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MYOSITIS, COMPRISING ISOLATED MITOCHONDRIA AS ACTIVE INGREDIENT (2026-05-26),

2. 12403160 - Injection composition containing isolated mitochondria, and use thereof (2025-09-02),

3. 12128070 - Natural killer cell containing exogenous mitochondrium and pharmaceutical composition comprising same (2024-10-29),

4. 11464953 - Water-soluble microneedle spicules and non-aqueous cosmetic composition containing the same (2022-10-11),

5. 11278569 - Natural killer cell containing exogenous mitochondrium and pharmaceutical composition comprising same (2022-03-22),

6. 10543160 - Cosmetic composition including water soluble scrub particles containing polypeptide and/or cell culture (2020-01-28),

7. 6987173 - Process for the preparation of active somatotropin from inclusion bodies (2006-01-17),

8. 6649382 - Methods of making polyhydroxyalkanoate using biosynthesis genes from alcaligenes latus (2003-11-18),

9. 6428997 - Aminopeptidase derived from Bacillus licheniformis and process for preparation of natural type proteins (2002-08-06),

Title: Kyuboem Han: Innovator in Mitochondrial Therapeutics

Introduction

Kyuboem Han is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of mitochondrial therapeutics, holding a total of 9 patents. His work focuses on developing pharmaceutical compositions that utilize isolated mitochondria for the prevention and treatment of various diseases.

Latest Patents

Among his latest patents is a groundbreaking pharmaceutical composition for preventing or treating myositis, which comprises isolated mitochondria as an active ingredient. This injection composition is designed to enhance the stability of mitochondria, ensuring their safety and activity when administered to patients. The composition aims to prevent and inhibit the formation of blood clots, addressing the challenges associated with mitochondrial dysfunction. By providing a safe and effective method for injecting mitochondria, Han's work has the potential to revolutionize treatments for diseases related to mitochondrial health.

Career Highlights

Kyuboem Han has worked with notable companies such as Paean Biotechnology Inc. and LG Chem Ltd. His experience in these organizations has allowed him to refine his expertise in biotechnology and pharmaceutical development. His innovative approaches have garnered attention in the scientific community, contributing to advancements in mitochondrial research.

Collaborations

Han has collaborated with esteemed colleagues, including Jongcheon Ha and Youngjun Lee. These partnerships have facilitated the exchange of ideas and fostered a collaborative environment for innovation in the field of mitochondrial therapeutics.

Conclusion

Kyuboem Han's contributions to mitochondrial therapeutics highlight his role as a leading inventor in this specialized area. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.